PharmaBoardroom

Dr Armin Wiesler, general manager and head of Human Pharma at Boehringer Ingelheim (Thai) Ltd., explores how the affiliate has managed to achieve…

Rare diseases and cell and gene therapy executive recruitment specialist Steve Smith outlines six key strategies for attracting and retaining talent…

Frost & Sullivan's Senior Research Analyst, Aarti Chitale looks at the sizeable impact that precision medicine, especially regenerative medicine,…

Rayne Waller, VP Manufacturing for Amgen Manufacturing Limited in Puerto Rico, is leading the operations at the company’s largest manufacturing…

Rodrigo Araujo of global organizational consulting firm Korn Ferry outlines what he sees as the leadership profile of the future - agile, digital,…

Andrea Sambatti is the general manager of Boehringer Ingelheim (BI) Sweden and is a member of the board of directors for LIF. Sambatti discusses how…

Dr Tianyi (Tee) Zhang, GM of Frontage China and SVP of Frontage Holdings, shares the significant growth of the China affiliate over the past four…

The bestselling drugs of 2018 in the USD 485 billion US pharma market. The list features several major blockbusters benefiting from the delays in…

All legal aspects surrounding regulatory reform in Germany. Prepared in association with Heuking Kühn Lüer Wojtek, a leading global law firm, this…

The legal framework for patents and trademarks in Germany. Prepared in association with Heuking Kühn Lüer Wojtek, a leading global law firm, this is…

An insight into product liability in Germany. Prepared in association with Heuking Kühn Lüer Wojtek, a leading global law firm, this is an extract…

The low-down on the situation regarding traditional medicines and OTC products in Germany. Prepared in association with Heuking Kühn Lüer Wojtek, a…